11+ hour, 6+ min ago   (509+ words) The winners were announced at the finale held in Bengaluru, in the presence of Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Limited Fifteen startups and four student teams have emerged as winners of the ninth edition of the C-CAMP National Bio Entrepreneurship…...

5+ day, 5+ hour ago   (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...

6+ day, 5+ hour ago   (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...

1+ week, 4+ hour ago   (57+ words) The technology targets some of the most difficult wounds to heal Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership to accelerate lab-to-market translation Fosun Pharma announces…...

1+ week, 6+ day ago   (85+ words) indianpharmapost.com Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials The results build on statistically superior outcomes reported at Week 36, when the combination outperformed Taltz alone on key disease and metabolic measures Chasing Consistency: Centralizing operations…...

1+ week, 6+ day ago   (65+ words) Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push on US drug pricing…...

2+ week, 2+ hour ago   (298+ words) Roche unit plans end-to-end fill-finish site in Hillsboro to support portfolio and pipeline injectables The planned facility will be built on the same campus as Genentech’s existing Hillsboro manufacturing site and will provide end-to-end fill-finish manufacturing for a range of…...

2+ week, 2+ day ago   (414+ words) Rs. 5,000-crore scheme invites applications from startups, MSMEs and industry across new medicines, biosimilars, novel medical devices and other priority areas The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has announced the second call for applications under the…...

2+ week, 2+ day ago   (652+ words) Engineered tRNA restores full-length protein production in cystic fibrosis models, opening the door to a potential new class of RNA therapeutics Researchers at the University of Toronto have developed a next-generation RNA therapeutic approach that could potentially treat a broad…...

2+ week, 6+ day ago   (361+ words) The latest transaction takes Natco Pharma’s total investment in Cambridge, Massachusetts-based eGenesis to $22 million Natco Pharma has invested an additional $14 million in eGenesis Inc., a US-based biotechnology company developing genome-engineered organs for transplantation, strengthening its exposure to the emerging field…...